EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totaling 3,171 shares, a growth of 77.4% from the March 15th total of 1,787 shares. Based on an average trading volume of 171,127 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on ESLOY. HSBC raised EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Wednesday, January 14th. Kepler Capital Markets raised EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Thursday, January 15th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, EssilorLuxottica presently has a consensus rating of "Buy".
Check Out Our Latest Analysis on ESLOY
EssilorLuxottica Price Performance
Shares of ESLOY stock opened at $116.26 on Monday. The stock has a 50 day simple moving average of $128.92 and a 200-day simple moving average of $154.68. EssilorLuxottica has a 12-month low of $109.00 and a 12-month high of $186.81. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.
EssilorLuxottica Company Profile
(
Get Free Report)
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EssilorLuxottica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.
While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.